Annual Report 2023

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2023 115 The United Laboratories International Holdings Limited Annual Report 2023 29. BORROWINGS 2023 2022 RMB’000 RMB’000 Bank loans 1,473,000 2,203,769 Discounted bills with recourse (Note 24) 23,853 251,378 1,496,853 2,455,147 Analysed as: Secured 23,853 251,378 Unsecured 1,473,000 2,203,769 1,496,853 2,455,147 The carrying amount of the bank loans are repayable: – Within one year 94,000 97,129 – Within a period of more than one year, but not exceeding two years 479,000 132,590 – Within a period of more than two years but not more than five years 820,000 963,199 1,393,000 1,192,918 The carrying amount of bank loans that contain a repayment on demand clause (shown under current liabilities) but repayable*: – Within one year 80,000 124,113 – Within a period of more than one year, but not exceeding two years – 434,398 – Within a period of more than two years but not more than five years – 452,340 1,473,000 2,203,769 The carrying amount of the non-bank loans are repayable: – Within one year 23,853 251,378 1,496,853 2,455,147 Less: Amount due within one year shown under current liabilities (197,853) (1,359,358) Amount shown under non-current liabilities 1,299,000 1,095,789 * The amounts due are based on scheduled repayment dates set out in the loan agreements.